$EG

EVEREST GROUP, LTD.

1
1
0

No SEC Form 4 filings for $EG in the last 30 days.

See all $EG insider activity →

Everest Group completes sale of Canadian retail unit

Everest Group (NYSE:EG) completed the sale of its Canadian retail unit to The Wawanesa Mutual Insurance Company, as announced Tuesday. The transaction, following a March 2026 agreement, is part of Everest's strategy to focus on reinsurance and specialty insurance. Wawanesa is a large Canadian insurer with over CAD$4 billion in annual revenue.

Is Everest Group Stock Underperforming the Dow?

Everest Group (EG), a global underwriting company, has seen its shares decline 7% from a 52-week high. Despite a 10% YTD gain, EG's 52-week return of 11.3% lags the Dow's 12.3%. Q2 2026 results showed an 11.8% revenue decline to $3.96B and a 14.5% drop in operating earnings. Analysts maintain a 'Moderate Buy' rating with a mean price target of $404.82.

EG sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning EG (EVEREST GROUP, LTD.). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.

Recent EG coverage spans earnings, financial news and corporate actions.

What's driving EG

AlphAI scores every news story that mentions EG with an AI model for sentiment and relevance, and aggregates insider trades from EVEREST GROUP, LTD.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $EG

Score
$EGLow

Is Everest Group Stock Underperforming the Dow?

Everest Group (EG), a global underwriting company, has seen its shares decline 7% from a 52-week high. Despite a 10% YTD gain, EG's 52-week return of 11.3% lags the Dow's 12.3%. Q2 2026 results showed an 11.8% revenue decline to $3.96B and a 14.5% drop in operating earnings. Analysts maintain a 'Moderate Buy' rating with a mean price target of $404.82.

The Zacks Analyst Blog Highlights RenaissanceRe, Arch Capital, Everest

Zacks highlights RenaissanceRe (RNR), Arch Capital (ACGL), and Everest (EG) as reinsurers benefiting from alternative capital. RNR reported $177.2M in fee income and $599.1M in underwriting income for Q2 2026. ACGL had $410M in underwriting income with a 77.5% combined ratio. EG's Mt. Logan platform grew to $3.4B in AUM. Estimates for 2026 earnings vary among the three.

$EGMed

Everest Group Stock: Analyst Estimates & Ratings

Everest Group (EG), a reinsurance and insurance provider, has a $14.5B market cap. Its stock rose 12% over 52 weeks, underperforming the S&P 500. Q2 2026 results showed an 11.8% revenue decline to $3.96B and a 14.5% drop in operating earnings. Analysts expect 19.6% EPS growth for 2026. The consensus rating is 'Moderate Buy' with a mean price target of $403.53.

$EGLow

Can Everest Sustain Underwriting Profitability Amid Soft Pricing?

Everest Group (EG) reported $317M in underwriting income with a 90% combined ratio in Q2 2026, despite a 7.1% drop in premiums. The company is prioritizing profitability over growth by reducing underpriced risks and focusing on specialty areas. EG's strategy aims to maintain underwriting discipline and portfolio optimization. Shares have gained 9.3% in the past year, but estimates for EPS have mixed. EG is rated as a Hold with a Value Score of A.

$EGMed

Everest (EG) Q2 2026 Earnings Call Transcript

Everest (EG) reported Q2 2026 earnings call results. It cited a combined ratio of 88.5% and underwriting income of $283 million, with gross written premium down about 9% YoY (constant dollars, excluding reinstatement). Property cat pricing fell about 10% between renewals, and Mount Logan Capital Management AUM was about $3.4B. Everest also said it repurchased $1.5B of shares since Jan 2025.

Related tickers